| Kat.-Nr. | Produktname | Informationen | Produktzitate | Produktvalidierungen |
|---|---|---|---|---|
| E1166 | Tetrathiomolybdate (TM) | Tetrathiomolybdate (TM) is used in the clinic for the treatment of Wilson’s disease by inducing dimerization of the metal-binding domain of the cellular copper efflux protein ATP7B (WLN4) through a unique sulfur-bridged Mo2S6O2 cluster. |
|